rxstat › Shortages › Hydrochlorothiazide Eprosartan

Hydrochlorothiazide Eprosartan shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Hydrochlorothiazide Eprosartan products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
8

Reports by product

Discontinued
TEVETEN PLUS
12.5MG 600MG · TABLET · BGP PHARMA ULC
DIN 02253631
Resolved
TEVETEN PLUS
12.5MG 600MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Aug 30, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVETEN PLUS
600MG 12.5MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Nov 2, 2020 · Disruption of the manufacture of the drug.
Avoided
TEVETEN PLUS
600MG 12.5MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Sep 28, 2020 · Requirements related to complying with good manufacturing practices.
Avoided
TEVETEN PLUS
600MG 12.5MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Aug 4, 2020 · Requirements related to complying with good manufacturing practices.
Resolved
TEVETEN PLUS
12.5MG 600MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Jul 10, 2020 · Delay in shipping of the drug.
Resolved
TEVETEN PLUS
12.5MG 600MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Apr 3, 2019 · Delay in shipping of the drug.
Resolved
TEVETEN PLUS
12.5MG 600MG · TABLET · BGP PHARMA ULC
DIN 02253631 · ended Jan 15, 2019 · Delay in shipping of the drug.

What's happening

One or more Hydrochlorothiazide Eprosartan products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Hydrochlorothiazide Eprosartan is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).

Recent changes

Common questions

When will Hydrochlorothiazide Eprosartan be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Hydrochlorothiazide Eprosartan in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, combinations)

Partial shortageAmlodipine Telmisartan2 of 6 reported products affectedPartial shortageHydrochlorothiazide Candesartan Cilexetil4 of 21 reported products affected · est. return Aug 31, 2026Partial shortageHydrochlorothiazide Irbesartan13 of 35 reported products affected · est. return Dec 4, 2026Partial shortageHydrochlorothiazide Losartan3 of 35 reported products affected · est. return Jul 7, 2026Partial shortageHydrochlorothiazide Valsartan5 of 27 reported products affected · est. return Jul 31, 2026Partial shortageOlmesartan Medoxomil Hydrochlorothiazide6 of 24 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.